State Street SPDR S&P Pharmaceuticals ETF (XPH) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

State Street SPDR S&P Pharmaceuticals ETF (XPH) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $238.3M, listed on AMEX, carrying a beta of 0.85 to the broader market. The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing public since 2006-06-22.

Snapshot as of May 15, 2026.

Spot Price
$56.92
Call OI
356
Put OI
151
Total OI
507
Put/Call Ratio
0.00

As of May 15, 2026, State Street SPDR S&P Pharmaceuticals ETF (XPH) has 507 total contracts outstanding across all expirations. Put/call OI ratio is 0.42 (call-heavy positioning). Open interest reflects accumulated positions from prior sessions; persistent growth indicates sustained directional or hedging interest, while sharp drops typically mean post-expiration clean-up.

How XPH open interest history Data Feeds Strategy Selection

Strategy selection on State Street SPDR S&P Pharmaceuticals ETF options does not derive from any single metric in isolation. The open interest history view above sits inside a broader read: ATM IV currently sits at 23.6% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the open interest history data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

Learn how open interest is reported and how to read the data →

Frequently asked XPH open interest history questions

What is the current XPH options open interest?
As of May 15, 2026, State Street SPDR S&P Pharmaceuticals ETF (XPH) has 507 total contracts outstanding across all listed expirations, split as 356 calls and 151 puts. Open interest reflects accumulated positions from prior trading sessions; it does not include today's volume until end-of-day reconciliation.
What is the XPH put/call open interest ratio?
Put/call OI ratio of 0.42 is call-heavy, often a directional bullish or upside-speculation signal.
What does XPH open interest tell traders?
Persistent OI growth indicates sustained directional or hedging interest; sharp drops typically mean post-expiration position cleanup. Heavy OI concentrations at specific strikes act as support and resistance levels because dealer hedging amplifies near those strikes - the gamma profile of the dealer book is concentrated there. Comparing today's volume to standing OI separates opening flow from closing flow.